TrialHuman vaccines & immunotherapeutics2017

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants.

Sanjay K Lalwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.